G.A. Edelstyn

780 total citations
27 papers, 480 citations indexed

About

G.A. Edelstyn is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G.A. Edelstyn has authored 27 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G.A. Edelstyn's work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Breast Cancer Therapies (4 papers). G.A. Edelstyn is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Breast Cancer Therapies (4 papers). G.A. Edelstyn collaborates with scholars based in United Kingdom, Ireland and Cyprus. G.A. Edelstyn's co-authors include Peter J. Gillespie, F. S. Grebbell, K D MacRae, A Lyons, Richard Welbourn, H W Rodgers, A. Taylor, Diana Brinkley, Michael Baum and James L. Alexander and has published in prestigious journals such as The Lancet, Cancer and British Journal of Cancer.

In The Last Decade

G.A. Edelstyn

24 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.A. Edelstyn United Kingdom 10 223 121 118 104 67 27 480
David L. Benninghoff United States 12 166 0.7× 142 1.2× 100 0.8× 38 0.4× 23 0.3× 37 523
B Blomstedt Sweden 13 148 0.7× 225 1.9× 80 0.7× 44 0.4× 19 0.3× 29 541
I Yamamoto Japan 10 215 1.0× 92 0.8× 52 0.4× 57 0.5× 110 1.6× 30 462
Mohammed Moinuddin United States 8 332 1.5× 114 0.9× 494 4.2× 230 2.2× 12 0.2× 26 676
Omar Hustu United States 8 107 0.5× 81 0.7× 128 1.1× 15 0.1× 52 0.8× 14 392
J. D. Elema Netherlands 13 65 0.3× 95 0.8× 114 1.0× 40 0.4× 27 0.4× 15 701
Jonathan Harris United States 6 156 0.7× 196 1.6× 104 0.9× 32 0.3× 74 1.1× 12 533
E Procaccini Italy 10 161 0.7× 188 1.6× 91 0.8× 97 0.9× 14 0.2× 25 433
W S Shand United Kingdom 12 136 0.6× 238 2.0× 90 0.8× 37 0.4× 22 0.3× 19 610
Doug Henderson United Kingdom 13 52 0.2× 136 1.1× 126 1.1× 76 0.7× 21 0.3× 25 486

Countries citing papers authored by G.A. Edelstyn

Since Specialization
Citations

This map shows the geographic impact of G.A. Edelstyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.A. Edelstyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.A. Edelstyn more than expected).

Fields of papers citing papers by G.A. Edelstyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.A. Edelstyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.A. Edelstyn. The network helps show where G.A. Edelstyn may publish in the future.

Co-authorship network of co-authors of G.A. Edelstyn

This figure shows the co-authorship network connecting the top 25 collaborators of G.A. Edelstyn. A scholar is included among the top collaborators of G.A. Edelstyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.A. Edelstyn. G.A. Edelstyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spittle, Margaret F, Bridget T. Hill, Marek Ostrowski, et al.. (1987). A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 23(8). 1155–1162. 6 indexed citations
2.
Spittle, M.F., Marek Ostrowski, K D MacRae, et al.. (1986). Adjuvant chemotherapy in the treatment of breast cancer: results of a multicentre study.. PubMed. 12(2). 109–16. 1 indexed citations
3.
Edelstyn, G.A., et al.. (1979). TRIALS OF ADJUVANT CHEMOTHERAPY IN BREAST CANCER. The Lancet. 313(8111). 324–325. 8 indexed citations
4.
Edelstyn, G.A., et al.. (1975). COMPARISON OF 5-DAY, 1-DAY, AND 2-DAY CYCLICAL COMBINATION CHEMOTHERAPY IN ADVANCED BREAST CANCER. The Lancet. 306(7927). 209–211. 12 indexed citations
5.
Edelstyn, G.A.. (1975). ADRIAMYCIN IN ADVANCED BREAST CANCER. The Lancet. 306(7944). 1095–1096. 4 indexed citations
6.
Gillespie, Peter J., et al.. (1975). Changes in 87mSr concentractions in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer.. PubMed. 16(3). 191–3. 26 indexed citations
7.
Edelstyn, G.A., et al.. (1974). Cyclical combination chemotherapy in advanced breast cancer.. PubMed. 54(6). 275–6. 1 indexed citations
8.
Edelstyn, G.A.. (1973). Norethisterone acetate (SH420) in advanced breast cancer. Cancer. 32(6). 1317–1320. 16 indexed citations
9.
Gillespie, Peter J., James L. Alexander, & G.A. Edelstyn. (1973). High concentration of 99mTc-sulfur colloid found during routine liver scan in lungs of patient with advanced breast cancer.. PubMed. 14(9). 711–2. 3 indexed citations
10.
Barr, Wallace, G.A. Edelstyn, David Förster, et al.. (1972). Treatment for ovarian carcinoma.. BMJ. 1(5802). 749.4–750. 2 indexed citations
11.
Edelstyn, G.A. & K D MacRae. (1972). TREATMENT OF BREAST CANCER. The Lancet. 300(7790). 1307–1307. 9 indexed citations
12.
Gillespie, Peter J., et al.. (1971). Possible Clinical Implications of Therapeutically Induced Temperature Changes in Continuously Monitored Tumour mass. British Journal of Cancer. 25(1). 85–92. 2 indexed citations
13.
Gillespie, Peter J., et al.. (1970). Rectally administered radio-iodide in the detection of hepatic metastases. Clinical Radiology. 21(3). 266–269. 2 indexed citations
14.
Edelstyn, G.A., et al.. (1968). Total hypophysectomy for advanced breast cancer. Clinical Radiology. 19(4). 426–432. 16 indexed citations
15.
Edelstyn, G.A., Peter J. Gillespie, & F. S. Grebbell. (1967). The radiological demonstration of osseous metastases. Experimental observations. Clinical Radiology. 18(2). 158–162. 238 indexed citations
16.
Lyons, A & G.A. Edelstyn. (1965). Thiotepa in the treatment of advanced breast cancer. British Journal of Cancer. 19(3). 490–495. 8 indexed citations
17.
Edelstyn, G.A., et al.. (1964). Attempted total hypophysectomy in advanced breast cancer. Report on a new method using both surgery and radiation. British journal of surgery. 51(1). 32–40. 7 indexed citations
18.
Edelstyn, G.A., A Lyons, & Richard Welbourn. (1961). THYROID FUNCTION IN THE PRESENCE OF BREAST CANCER. The Lancet. 277(7183). 943–943.
19.
Edelstyn, G.A., A Lyons, & Richard Welbourn. (1958). THYROID FUNCTION IN PATIENTS WITH MAMMARY CANCER. The Lancet. 271(7022). 670–671. 33 indexed citations
20.
Edelstyn, G.A.. (1958). Hormonal control of breast cancer. Irish Journal of Medical Science (1971 -). 33(9). 428–431. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026